VIRACEPT
Live / Registered — Registered and renewed (as of 05 Nov 2016)
What this means for you
Registered since 15 Oct 1996. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal was filed 15 Sept 2026 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 74683161
- Registration number
- 2007831
- Mark type
- Word mark
- Filed
- 01 Jun 1995
- Published for opposition
- 23 Jul 1996
- Registered
- 15 Oct 1996
- Current term from
- 15 Oct 2016
- Next maintenance filing
- §8 & §9 renewal, filed 15 Sept 2026 — awaiting the USPTO's acceptance
- Attorney of record
- Andrea Christensen
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals * , namely anti-virals for use in the treatment of viral diseases *
Owner
- AGOURUN PHARMACEUTICALS, LLC, SAN DIEGO, CA, US
- Agouron Pharmaceuticals, Inc., La Jolla, CA, US
- Agouron Pharmaceuticals, Inc., La Jolla, CA, US
- Agouron Pharmaceuticals, Inc., La Jolla, CA, US
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 15 Sept 2026 — TEAS SECTION 8 & 9 RECEIVED
- 29 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Oct 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 03 Jun 2020 — REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
- 23 May 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Mar 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 Mar 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Mar 2020 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 17 Mar 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Mar 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Mar 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Nov 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED